Amyloidosis Center – BUSM, Boston Medical Center

Patient Information

Unique in its approach, the Amyloidosis Center provides exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research

Support Amyloidosis Research & Clinical Innovation

Our laboratory and clinical research is supported by grants from the government and from foundations, and by individual donations. These are vital for support of our mission to help us in our quest for a cure for amyloidosis.

Donate Now

Researchers and Physicians

Amyloidosis News

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

The HELIOS B trial, recently published in NEJM, has unveiled promising results for patients with ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran, a cutting-edge siRNA therapy, significantly reduced the risk of death and cardiac events compared to placebo. Over 36 months, Vutrisiran also showed improvements in walking distance and quality of life. These findings highlight a […]

Read more
View All